Found: 47
Select item for more details and to access through your institution.
Differences in management approaches for lupus nephritis within the UK.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 1, p. 1, doi. 10.1093/rap/rkae017
- By:
- Publication type:
- Article
Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkab106
- By:
- Publication type:
- Article
The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review.
- Published in:
- Rheumatology, 2016, v. 55, n. 3, p. 485, doi. 10.1093/rheumatology/kev343
- By:
- Publication type:
- Article
Concomitant cyclophosphamide and oral immunosuppressants with rituximab for systemic lupus erythematosus.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Concomitant cyclophosphamide and oral immunosuppressants with rituximab for systemic lupus erythematosus.
- Published in:
- 2012
- By:
- Publication type:
- Letter
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus.
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1837, doi. 10.1093/rheumatology/keae041
- By:
- Publication type:
- Article
Revision to the musculoskeletal domain of the BILAG-2004 index to incorporate ultrasound findings.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. 498, doi. 10.1093/rheumatology/kead241
- By:
- Publication type:
- Article
More to B: the growing evidence to inform targeting B cells in scleroderma.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4905, doi. 10.1093/rheumatology/keac150
- By:
- Publication type:
- Article
Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index.
- Published in:
- Rheumatology, 2022, v. 61, n. 10, p. 4006, doi. 10.1093/rheumatology/keab883
- By:
- Publication type:
- Article
Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study.
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5194, doi. 10.1093/rheumatology/keab288
- By:
- Publication type:
- Article
De novo lupus nephritis during treatment with belimumab.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4348, doi. 10.1093/rheumatology/keaa796
- By:
- Publication type:
- Article
Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis.
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2838, doi. 10.1093/rheumatology/kez676
- By:
- Publication type:
- Article
Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus.
- Published in:
- Rheumatology, 2019, v. 58, n. 8, p. 1353, doi. 10.1093/rheumatology/key422
- By:
- Publication type:
- Article
244 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
242 Baseline characteristics of patients with lupus nephritis requiring rituximab therapy: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR).
- Published in:
- 2019
- By:
- Publication type:
- Abstract
191 Effectiveness and safety of switch to rituximab biosimilar with rheumatoid arthritis. a single centre experience.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 304, doi. 10.1093/rheumatology/key277
- By:
- Publication type:
- Article
Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy.
- Published in:
- Rheumatology, 2017, v. 56, n. 10, p. 1662, doi. 10.1093/rheumatology/kew431
- By:
- Publication type:
- Article
Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
- Published in:
- Rheumatology, 2017, v. 56, n. 8, p. 1348, doi. 10.1093/rheumatology/kex072
- By:
- Publication type:
- Article
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
A glimpse into the future of systemic lupus erythematosus.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2022, p. 1, doi. 10.1177/1759720X221086719
- By:
- Publication type:
- Article
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 8, p. 689, doi. 10.1002/acr2.11466
- By:
- Publication type:
- Article
Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 697, doi. 10.1002/art.42404
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 5, p. 769, doi. 10.1002/art.41187
- By:
- Publication type:
- Article
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1812, doi. 10.1002/art.40937
- By:
- Publication type:
- Article
Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1586, doi. 10.1002/art.39085
- By:
- Publication type:
- Article
Correction: Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03089-5
- By:
- Publication type:
- Article
Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03089-5
- By:
- Publication type:
- Article
Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 210, doi. 10.1093/bjd/ljad089
- By:
- Publication type:
- Article
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19918-z
- By:
- Publication type:
- Article
A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 3, p. 781, doi. 10.1007/s40744-022-00442-z
- By:
- Publication type:
- Article
Advances in the Treatment of Early Rheumatoid Arthritis.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Investigation of type I interferon responses in ANCA-associated vasculitis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87760-4
- By:
- Publication type:
- Article
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus.
- Published in:
- Lupus, 2021, v. 30, n. 8, p. 1254, doi. 10.1177/09612033211014267
- By:
- Publication type:
- Article
Keratinocytes: From passive targets to active mediators of systemic autoimmunity.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 642, p. 1, doi. 10.1126/scitranslmed.abo3961
- By:
- Publication type:
- Article
Development and Validation of the OMERACT Rheumatoid Arthritis Magnetic Resonance Tenosynovitis Scoring System in a Multireader Exercise.
- Published in:
- 2017
- By:
- Publication type:
- journal article
IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 12, p. 2935, doi. 10.1038/jid.2015.317
- By:
- Publication type:
- Article
Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01336
- By:
- Publication type:
- Article
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.803175
- By:
- Publication type:
- Article
Choosing the Right Rituximab Dose for the Right Patient: Comment on the Article by Bredemeier et al.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 10, p. 1591, doi. 10.1002/acr.22379
- By:
- Publication type:
- Article
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1445-3
- By:
- Publication type:
- Article
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1190-z
- By:
- Publication type:
- Article
Biologics in systemic lupus erythematosus: current options and future perspectives.
- Published in:
- British Journal of Hospital Medicine (17508460), 2014, v. 75, n. 8, p. 440, doi. 10.12968/hmed.2014.75.8.440
- By:
- Publication type:
- Article